Reply to thread

Well this is the problem we already have with the current standard which is the PSA test. It looks like this Stockholm-3 testing could lead to fewer unnecessary biopsies and less overtreatment. But it's the same over here, breast cancer gets FAR more publicity and funding than prostate cancer.


Back
Top